We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$2.39B
AUM Growth
+$171M
(+7.7%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
35.58%
Holding
318
New
36
Increased
76
Reduced
22
Closed
16
Avg Time Held
3.6
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
4.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Equal Weighted ETF
EUSA
|
+$13.3M |
| 2 |
Caterpillar
CAT
|
+$11.8M |
| 3 |
Vertiv
VRT
|
+$9.23M |
| 4 |
Novo Nordisk
NVO
|
+$1.11M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$13.5M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$6.68M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$4.93M |
| 4 |
Deckers Outdoor
DECK
|
+$1.35M |
| 5 |
Henry Schein
HSIC
|
+$845K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.15% |
| 2 | Industrials | 14.13% |
| 3 | Financials | 12.77% |
| 4 | Healthcare | 9.64% |
| 5 | Consumer Discretionary | 9.46% |
Similar funds
Henshaw Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Henshaw Capital held 318 positions worth $2.39B, up 7.7% from $2.22B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Henshaw Capital's Q3 2024 filing shows 36 new, 76 increased, 22 reduced and 16 closed positions. Its largest new stake was Caterpillar: 34,060 shares worth $13.3M. The largest sale was Pfizer, an estimated $13.5M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Industrials and Financials.
- Henshaw Capital's largest Q3 2024 buy was Caterpillar: 34,060 shares worth $13.3M.
- Henshaw Capital added most to iShares MSCI USA Equal Weighted ETF in Q3 2024, an estimated $13.3M increase.
- Henshaw Capital's biggest Q3 2024 reduction was Pfizer, cutting an estimated $13.5M.
- Henshaw Capital fully exited Vanguard FTSE All-World ex-US ETF in Q3 2024, selling an estimated $6.68M.
- Henshaw Capital's ten largest holdings make up 36% of its $2.39B portfolio in Q3 2024.
- Henshaw Capital opened 36 new positions and closed 16 in Q3 2024.
- Henshaw Capital's portfolio value rose 7.7% quarter-over-quarter to $2.39B.
Based on Henshaw Capital's 13F filing for Q3 2024, filed 28 May 2026.